TapewireFind a company

person · Reporting owner

Dudum Andrew

Disclosed activity across 1 company

Tapewire entity
18974
SEC CIK
0001837796

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Hims & Hers Health, Inc.HIMS · Entity 1878Director · Chief Executive Officer · 10% ownerAugust 25, 2026August 28, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date August 25, 2026 · Filed August 28, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Gift · Disposed 463,289 · Balance 0

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT463,289 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 463,289

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Legacy 2021 Trust103,406 Reported balance After 2026-08-27 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 5 · 2026-08-27 · Other · Disposed 977,566 · Balance 103,406

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Class A Common StockSEC Table I · non-derivativeDirect1,033,177 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,033,177

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015573,202 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 573,202

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2025 GRAT dated 5-27-202542,993 Reported balance Holding disclosure · report date 2026-08-25 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 42,993

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Community Property Trust470,457 Reported balance Holding disclosure · report date 2026-08-25 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 470,457

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022791,117 Reported balance Holding disclosure · report date 2026-08-25 · row 8 Holding and transaction disclosures are not merged.
1 source row

Row 8 · Balance 791,117

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-20212,214,769 Reported balance Holding disclosure · report date 2026-08-25 · row 9 Holding and transaction disclosures are not merged.
1 source row

Row 9 · Balance 2,214,769

Class A Common StockSEC Table I · non-derivativeIndirectHeld by Trustee of Dudum Family 2021 Trust3,004,071 Reported balance Holding disclosure · report date 2026-08-25 · row 10 Holding and transaction disclosures are not merged.
1 source row

Row 10 · Balance 3,004,071

Filing footnotes · ownership attribution and instrument terms

F1: This amount reflects an annuity payment-in-kind of 44,741 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT.

F2: The reported transaction involves a transfer of securities by bona fide gift for which no payment of consideration was received by the Reporting Person.

F3: This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 977,566 shares of Class A Common Stock for bona fide estate planning purposes.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 20, 2024 Filed Jun 21, 2024 20:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 26,741 $23.37 $624,832.88
Disclosure

SEC source: 0001773751-24-000209 · wk-form4_1719001876.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,202

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $22.92 - $23.91. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 20, 2024 Filed Jun 21, 2024 20:31 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 18,314 $22.35 $409,239.15
Disclosure

SEC source: 0001773751-24-000209 · wk-form4_1719001876.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,943

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.92 - $22.91. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 74,529 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 20

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,117,948

Underlying: Class A Common Stock · 74,529 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,290 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,867

Underlying: Class A Common Stock · 18,290 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,789 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,367

Underlying: Class A Common Stock · 1,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 3,576 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 17

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,726

Underlying: Class A Common Stock · 3,576 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 107 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 16

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321

Underlying: Class A Common Stock · 107 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 7,330 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,990

Underlying: Class A Common Stock · 7,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,242 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,694

Underlying: Class A Common Stock · 35,242 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,446 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · derivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,912

Underlying: Class A Common Stock · 35,446 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 97,052 $23.75 $2,304,985.00
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,257

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
June 14, 2024 Filed Jun 18, 2024 21:27 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 176,309 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000200 · wk-form4_1718746031.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,309

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 188,888 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,148,456

Underlying: Class A Common Stock · 188,888 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 53,452 $20.13 $1,076,122.39
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,165,978

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00- $20.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 90,992 $19.73 $1,795,235.76
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,219,430

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.41- $19.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 69,839 $20.13 $1,406,026.68
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00- $20.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 119,049 $19.73 $2,348,812.96
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,839

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.41- $19.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 22:47 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 188,888 $2.43 $458,997.84
Disclosure

SEC source: 0001773751-24-000162 · wk-form4_1717627629.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 188,888 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000125 · wk-form4_1714775923.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,337,344

Underlying: Class A Common Stock · 188,888 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 144,444 $12.69 $1,832,416.58
Disclosure

SEC source: 0001773751-24-000125 · wk-form4_1714775923.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,310,422

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.32- $13.16. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 94,444 $12.53 $1,183,685.54
Disclosure

SEC source: 0001773751-24-000125 · wk-form4_1714775923.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.29- $13.015. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 94,444 $12.54 $1,184,204.98
Disclosure

SEC source: 0001773751-24-000125 · wk-form4_1714775923.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,444

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.30- $13.015. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 22:38 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 188,888 $2.43 $458,997.84
Disclosure

SEC source: 0001773751-24-000125 · wk-form4_1714775923.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 188,888 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · derivative · entry 17

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,526,232

Underlying: Class A Common Stock · 188,888 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 15,898 $15.39 $244,593.91
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 7

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,454,866

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.28 - 15.71. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 128,546 $14.70 $1,890,024.69
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 6

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,470,764

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.20 - 15.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 1,010 $15.63 $15,790.44
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 5

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.685. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 93,434 $14.97 $1,399,015.31
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,010

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.45 - 15.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 923 $15.63 $14,428.61
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,444

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 93,521 $14.96 $1,398,840.36
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,367

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.44 - 15.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 22:33 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 188,888 $2.43 $458,997.84
Disclosure

SEC source: 0001773751-24-000098 · wk-form4_1712615598.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

Read SEC document
March 20, 2024 Filed Mar 21, 2024 23:08 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 50,361 $16.34 $823,054.86
Disclosure

SEC source: 0001773751-24-000089 · wk-form4_1711062479.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.86 - $16.575. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 9,924 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 21

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 9,924 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 198 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 20

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 198 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2020.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 18,289 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 19

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,157

Underlying: Class A Common Stock · 18,289 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 1,789 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 18

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,156

Underlying: Class A Common Stock · 1,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 3,575 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 17

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,302

Underlying: Class A Common Stock · 3,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 106 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 16

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 428

Underlying: Class A Common Stock · 106 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 7,330 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 15

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,320

Underlying: Class A Common Stock · 7,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,242 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 14

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,936

Underlying: Class A Common Stock · 35,242 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionRestricted Stock Unit · Derivative 35,447 $0.00 $0.00
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · derivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,358

Underlying: Class A Common Stock · 35,447 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Tax withholdingClass A Common Stock 61,539 $14.63 $900,315.57
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,361

F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:02 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 111,900 Not disclosed Not disclosed
Disclosure

SEC source: 0001773751-24-000074 · wk-form4_1710885717.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 21:43 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 188,896 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · derivative · entry 13

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,715,120

Underlying: Class A Common Stock · 188,896 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 21:43 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 144,448 $13.07 $1,888,022.03
Disclosure

SEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 3

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015

Disclosed balance after: 1,599,310

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.73 - $13.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 21:43 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 240,549 $13.07 $3,144,119.76
Disclosure

SEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.73 - $13.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 21:43 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 188,896 $2.43 $459,017.28
Disclosure

SEC source: 0001773751-24-000049 · wk-form4_1709588205.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 240,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 21:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionStock Option (right to buy) · Derivative 577,007 $0.00 Strike: $2.43 $0.00
Disclosure

SEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · derivative · entry 4

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,904,016

Underlying: Class A Common Stock · 577,007 shares

Expires 2030-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 21:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 SaleClass A Common Stock 577,007 $12.96 $7,480,261.05
Disclosure

SEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · nonDerivative · entry 2

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,653

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 21:06 UTC Hims & Hers Health, Inc. HIMS · Entity 1878 Exercise / conversionClass A Common Stock 577,007 $2.43 $1,402,127.01
Disclosure

SEC source: 0001773751-24-000041 · wk-form4_1709327152.xml · nonDerivative · entry 1

Dudum Andrew · CIK 0001837796 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 628,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.